Home/Filings/4/0000921895-18-003075
4//SEC Filing

Perelman Vadim 4

Accession 0000921895-18-003075

CIK 0001040719other

Filed

Nov 14, 7:00 PM ET

Accepted

Nov 15, 6:25 PM ET

Size

24.1 KB

Accession

0000921895-18-003075

Insider Transaction Report

Form 4
Period: 2018-11-13
Transactions
  • Sale

    Common Stock

    2018-11-13$0.66/sh391,728$257,56157 total(indirect: By: Baker Street Capital L.P.)
  • Sale

    Common Stock

    2018-11-13$0.66/sh76,896$50,5590 total(indirect: By: Baskerville SPV, L.P.)
Holdings
  • Common Stock

    7,283
  • Series A Warrants

    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (12,449 underlying)
    12,449
  • Series B Warrants

    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (9,878 underlying)
    9,878
  • Series A Warrants

    (indirect: By: Baker Street Capital L.P.)
    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (710,074 underlying)
    710,074
  • Series B Warrants

    (indirect: By: Baker Street Capital L.P.)
    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (563,429 underlying)
    563,429
  • Series A Warrants

    (indirect: By: Baskerville SPV, L.P.)
    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (131,009 underlying)
    131,009
  • Series B Warrants

    (indirect: By: Baskerville SPV, L.P.)
    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (103,952 underlying)
    103,952
Transactions
  • Sale

    Common Stock

    2018-11-13$0.66/sh391,728$257,56157 total(indirect: By: Baker Street Capital L.P.)
  • Sale

    Common Stock

    2018-11-13$0.66/sh76,896$50,5590 total(indirect: By: Baskerville SPV, L.P.)
Holdings
  • Series B Warrants

    (indirect: By: Baker Street Capital L.P.)
    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (563,429 underlying)
    563,429
  • Series A Warrants

    (indirect: By: Baskerville SPV, L.P.)
    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (131,009 underlying)
    131,009
  • Series B Warrants

    (indirect: By: Baskerville SPV, L.P.)
    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (103,952 underlying)
    103,952
  • Common Stock

    7,283
  • Series A Warrants

    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (12,449 underlying)
    12,449
  • Series B Warrants

    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (9,878 underlying)
    9,878
  • Series A Warrants

    (indirect: By: Baker Street Capital L.P.)
    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (710,074 underlying)
    710,074
Transactions
  • Sale

    Common Stock

    2018-11-13$0.66/sh391,728$257,56157 total(indirect: By: Baker Street Capital L.P.)
  • Sale

    Common Stock

    2018-11-13$0.66/sh76,896$50,5590 total(indirect: By: Baskerville SPV, L.P.)
Holdings
  • Series A Warrants

    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (12,449 underlying)
    12,449
  • Series B Warrants

    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (9,878 underlying)
    9,878
  • Series B Warrants

    (indirect: By: Baker Street Capital L.P.)
    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (563,429 underlying)
    563,429
  • Series A Warrants

    (indirect: By: Baskerville SPV, L.P.)
    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (131,009 underlying)
    131,009
  • Series B Warrants

    (indirect: By: Baskerville SPV, L.P.)
    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (103,952 underlying)
    103,952
  • Common Stock

    7,283
  • Series A Warrants

    (indirect: By: Baker Street Capital L.P.)
    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (710,074 underlying)
    710,074
Transactions
  • Sale

    Common Stock

    2018-11-13$0.66/sh391,728$257,56157 total(indirect: By: Baker Street Capital L.P.)
  • Sale

    Common Stock

    2018-11-13$0.66/sh76,896$50,5590 total(indirect: By: Baskerville SPV, L.P.)
Holdings
  • Common Stock

    7,283
  • Series A Warrants

    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (12,449 underlying)
    12,449
  • Series B Warrants

    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (9,878 underlying)
    9,878
  • Series A Warrants

    (indirect: By: Baker Street Capital L.P.)
    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (710,074 underlying)
    710,074
  • Series B Warrants

    (indirect: By: Baker Street Capital L.P.)
    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (563,429 underlying)
    563,429
  • Series A Warrants

    (indirect: By: Baskerville SPV, L.P.)
    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (131,009 underlying)
    131,009
  • Series B Warrants

    (indirect: By: Baskerville SPV, L.P.)
    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (103,952 underlying)
    103,952
Transactions
  • Sale

    Common Stock

    2018-11-13$0.66/sh391,728$257,56157 total(indirect: By: Baker Street Capital L.P.)
  • Sale

    Common Stock

    2018-11-13$0.66/sh76,896$50,5590 total(indirect: By: Baskerville SPV, L.P.)
Holdings
  • Common Stock

    7,283
  • Series A Warrants

    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (12,449 underlying)
    12,449
  • Series B Warrants

    (indirect: By: Baskerville SPV, L.P.)
    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (103,952 underlying)
    103,952
  • Series B Warrants

    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (9,878 underlying)
    9,878
  • Series A Warrants

    (indirect: By: Baker Street Capital L.P.)
    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (710,074 underlying)
    710,074
  • Series B Warrants

    (indirect: By: Baker Street Capital L.P.)
    Exercise: $28.25From: 2018-02-09Exp: 2028-02-09Common Stock (563,429 underlying)
    563,429
  • Series A Warrants

    (indirect: By: Baskerville SPV, L.P.)
    Exercise: $20.63From: 2018-02-09Exp: 2028-02-09Common Stock (131,009 underlying)
    131,009
Footnotes (3)
  • [F1]This Form 4 is filed jointly by Baker Street Capital L.P. ("BSC LP"), Baskerville SPV, L.P. ("Baskerville SPV"), Baker Street Capital GP, LLC ("BSC GP"), Baker Street Capital Management, LLC ("Baker Street Capital Management") and Vadim Perelman (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that owns more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the shares of Common Stock reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such shares of Common Stock for purposes of Section 16 or for any other purpose.
  • [F2]Represents securities owned directly by BSC LP. BSC GP, as the general partner of BSC LP, may be deemed to beneficially own the securities owned by BSC LP. Baker Street Capital Management, as the investment manager of BSC LP, may be deemed to beneficially own the securities owned by BSC LP. Mr. Perelman, as the managing member of each of BSC GP and Baker Street Capital Management, may be deemed to beneficially own the securities owned by BSC LP.
  • [F3]Represents securities owned directly by Baskerville SPV. BSC GP, as the general partner of Baskerville SPV, may be deemed to beneficially own the securities owned by Baskerville SPV. Baker Street Capital Management, as the investment manager of Baskerville SPV, may be deemed to beneficially own the securities owned by Baskerville SPV. Mr. Perelman, as the managing member of each of BSC GP and Baker Street Capital Management, may be deemed to beneficially own the securities owned by Baskerville SPV.

Issuer

DITECH HOLDING Corp

CIK 0001040719

Entity typeother

Related Parties

1
  • filerCIK 0001489810

Filing Metadata

Form type
4
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 6:25 PM ET
Size
24.1 KB